Mitochondrial transplantation ameliorates experimental autoimmune encephalomyelitis by modulating the Th17/Treg balance and restoring metabolic homeostasis
Frontiers in Immunology · 16.03.2026 · 17
DOI: 10.3389/fimmu.2026.1698136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Immunology, online erschienen am 16.03.2026. Verfasst von A Ram Lee und 12 weiteren Autor:innen. Beteiligte Einrichtung: Lab of Translational ImmunoMedicine, Catholic Research Institute of Medical Science, College of Medicine, College of Medicine, The Catholic Universit…. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Th17 Cells, Mitochondria, T-Lymphocytes, Regulatory. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Mitochondrial dysfunction has been increasingly implicated in the pathogenesis of multiple sclerosis (MS), contributing to oxidative stress, immune dysregulation, and neurodegeneration. Current therapies primarily target inflammation but do not adequately address mitochondrial impairment or progressive tissue damage. This study aimed to evaluate the therapeutic potential of mitochondrial transplantation in experimental autoimmune encephalomyelitis (EAE), a murine model of MS, by investigating its effects on immune modulation, mitochondrial function, and tissue integrity.
Methods
EAE was induced in mice using myelin oligodendrocyte glycoprotein. Isolated mitochondria were administered intravenously, and clinical progression, spinal cord histology, immune cell populations, mitochondrial activity, fibrosis, and gut microbiota composition were assessed. Additionally, human peripheral blood mononuclear cells (PBMCs) from MS patients were co-cultured with mitochondria to examine ATP production, reactive oxygen species levels, and T cell differentiation.
Results
Mitochondrial transplantation significantly reduced EAE severity, spinal cord inflammation, demyelination, and fibrosis. Treated mice showed increased regulatory T (Treg) cells, reduced T helper 17 (Th17) cells, improved mitochondrial biogenesis, and decreased oxidative stress. Gut microbiome analysis revealed beneficial compositional changes. In human PBMCs, mitochondrial transfer enhanced ATP synthesis, suppressed mitochondrial ROS, and promoted Treg differentiation while inhibiting pro-inflammatory cytokines.
Discussion
Our findings suggest that mitochondrial transplantation restores mitochondrial function, rebalances immune responses, and mitigates neuroinflammation and fibrosis in EAE. This approach offers a novel therapeutic strategy for MS by addressing both metabolic and immunological drivers of disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lab of Translational ImmunoMedicine, Catholic Research Institute of Medical Science, College of Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Mitochondrial Immunomedicine center for Global Health Therapeutics (MIGHT), Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Biomedicine and Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
- Department of Food and Nutrition, College of Human Ecology, Kyung Hee University, Seoul, Republic of Korea.
- Department of Neurology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Zitieren
APA
Lee, A. R., Yang, S. W., Lee, S. Y., Jeon, S. B., Kang, H. Y., Choi, J. W., Park, J. H., Park, J. H., Son, S. B., Jeong, Y., Lee, J. H., Kim, W., & Cho, M. L. (2026). Mitochondrial transplantation ameliorates experimental autoimmune encephalomyelitis by modulating the Th17/Treg balance and restoring metabolic homeostasis. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1698136
Vancouver
Lee AR, Yang SW, Lee SY, Jeon SB, Kang HY, Choi JW, et al. Mitochondrial transplantation ameliorates experimental autoimmune encephalomyelitis by modulating the Th17/Treg balance and restoring metabolic homeostasis. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1698136
BibTeX
@article{Lee2026,
author = {Lee, A Ram and Yang, Suh Won and Lee, Seon-Yeong and Jeon, Su Been and Kang, Hye Yeon and Choi, Jeong Won and Park, Jin Hyung and Park, Ju Hyeon and Son, Su Bin and Jeong, Yunju and Lee, Jung Hwan and Kim, Woojun and Cho, Mi-La},
title = {Mitochondrial transplantation ameliorates experimental autoimmune encephalomyelitis by modulating the Th17/Treg balance and restoring metabolic homeostasis},
journal = {Frontiers in Immunology},
year = {2026},
volume = {17},
doi = {10.3389/fimmu.2026.1698136}
}
EUVIMED